TodaysStocks.com news host Pat Bolland interviews CEO Ron Rocca from Exagen Inc.    

Exagen (NASDAQ: XGN) is a leading provider of autoimmune diagnostic, prognostic, and monitoring testing solutions.  Exagen is a patient focused, discovery driven organization built on the success of AVISE testing and is investing in its product pipeline to support patients throughout their autoimmune diagnosis and treatment. Exagen’s goal is to assist patients, physicians, and payors by enabling precision medicine. Exagen is located in San Diego County with clinical and research and development laboratories in Vista, CA.  Ron Rocca and Pat Bolland's discussion was centred on the Exagen Inc press release dated July 5, 2022 https://stockmkt.info/3yOyPzK 

0:16 CAPSTONE Study 

0:56 1st finding 

1:14 2nd finding 

1:58 3rd finding 

2:30 4th finding 

2:43 5th finding 

3:00 Size of study 

3:30 How long does the study take 

4:45 Business side of things  

Learn more about Exagen Inc. on their website www.Exagen.com

Exagen Inc. (NASDAQ: XGN) is a patient-focused and discovery-driven commercial-stage life sciences company, that aids patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. A relentless pursuit for laboratory excellence has enabled Exagen to develop next-generation autoimmune testing to help empower physicians and improve patients' lives.  

Learn more about Exagen Inc on their website https://exagen.com/ 

================================================================= 

TodaysStocks.com Today's News for Tomorrows Investor  

Find out more @ https://todaysstocks.com/   

Want to book a CEO Interview with Pat Bolland? Click here↓  

https://stockmkt.info/3wQaurn   

Want to book a News Release Interview with Natalie Stoberman? Click here↓ 

https://stockmkt.info/3wRITY5   

Follow us Facebook: https://www.facebook.com/TodaysStocksNow   

Follow us on Twitter: https://twitter.com/TodaysStocksNow 

________________________________________________________________   

TodaysStocks.com does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of TodaysStocks.com and do not constitute investment advice. All readers and viewers are encouraged to perform their own due diligence.